spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Solagé 

 HSMN NewsFeed - 15 Oct 2010
Nicholas L. Teti, Jr. Appointed President and CEO of Suneva Medical
Devices Personnel
 HSMN NewsFeed - 5 Mar 2009
Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 6 Aug 2008
Stiefel Laboratories Completes Acquisition of Barrier Therapeutics
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 5 Aug 2008
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 28 Jul 2008
Barrier Therapeutics Introduces Dual-Component Xolegel CorePak(TM) for Seborrheic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Jul 2008
Stiefel Laboratories, Inc. Commences Tender Offer to Acquire Barrier Therapeutics, Inc.
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 23 Jun 2008
Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 23 Jun 2008
Barrier Therapeutics to Merge Into Stiefel Laboratories
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 22 May 2008
Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Mar 2008
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 15 Jan 2008
Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Jan 2008
Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO)
Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Nov 2007
Isolagen Initiates Phase III Clinical Program to Investigate Isolagen Therapy(TM) for the Treatment of Acne Scars
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 28 Sep 2007
Barrier Therapeutics Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Hyphanox(TM) for Onychomycosis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Aug 2007
Barrier Therapeutics Introduces New Xolegel Duo(TM) Offering at the American Academy of Dermatology (AAD) Summer Academy Meeting 2007
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Jul 2007
Barrier Therapeutics Announces Positive Phase 2 Data With Oral Rambazole in Moderate to Severe Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 6 Jul 2007
Isolagen, Inc. Promotes Declan Daly to Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 14 Jun 2007
Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 16 May 2007
Barrier Therapeutics Appoints Dr. Braham Shroot, Dermatology Expert, as New Chief Scientific Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 3 May 2007
Barrier Therapeutics Receives FDA Approval for Solagé(R) Topical Solution Labeling Expansion
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 27 Mar 2007
Barrier Therapeutics Announces Azoline (Pramiconazole) Dose Ranging Study in Tinea Versicolor Meets Primary and Secondary Endpoints
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Mar 2007
Barrier Therapeutics Receives Regulatory Approval to Market Xolegel(TM) in Canada
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 6 Mar 2007
Barrier Therapeutics Announces Agreement to Co-Promote Vusion(TM) Ointment to Pediatricians in the United States
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Feb 2007
Isolagen, Inc. Names Sandra Calman, M.D. Vice President of Clinical Development and Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 8 Nov 2006
Isolagen, Inc. Announces Proposal to Close Isolagen Europe Ltd.
Regenerative Medicine
 HSMN NewsFeed - 13 Oct 2006
Isolagen and FDA Reach Agreement on Phase III Protocol Design
Regenerative Medicine FDA
 HSMN NewsFeed - 10 Oct 2006
Isolagen Adds Key Executive
Regenerative Medicine Personnel
Return to NewsFeed  

 Additional items found! 29

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 29 additional stories matching:
Solagé
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.